{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006915",
      "entity_text" : "apoptosis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:NFkappaB",
      "entity_text" : "NF-kappaB",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The abnormal activation of NF-kappaB contributes to significant cell proliferation and migration in CRC and in other types of cancer, and the inhibition of NF-kappaB activity has been shown to significantly reduce cancer cell growth and enhance cell apoptosis, indicating that NF-kappaB members are potential therapeutic targets in tumors.",
  "reading_complete" : "2020-08-02T15:33:42Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T15:32:36Z",
  "trigger" : "enhance",
  "evidence" : [ "NF-kappaB activity has been shown to significantly reduce cancer cell growth and enhance cell apoptosis" ],
  "pmc_id" : "4380201",
  "score" : 0
}